![Emma Beausang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emma Beausang formerly worked at Aerie Pharmaceuticals, Inc., as Vice President-Regulatory Affairs and GH Research Plc, as VP-Regulatory Affairs & Quality Assurance.
Dr. Beausang received her doctorate degree from UCL School of Pharmacy and undergraduate degree from the University of Strathclyde.
| Unternehmen | Position | Ende |
|---|---|---|
| GH RESEARCH PLC | General Counsel | 02.04.2024 |
| AERIE PHARMACEUTICALS, INC. | General Counsel | 01.12.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCL School of Pharmacy
 UCL School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GH Research Plc
 GH Research Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapies for the management of psychiatric and neurological disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
